abstract: Tubal assessment is an integral part of female fertility evaluation. While diagnostic laparoscopy is gold standard, it is not suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available. The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.
Background
Fallopian tube abnormalities account for up to 40% of female subfertility (Snick et al., 1997; Steinkeler et al., 2009) . Assessment of tubal patency is one of the first steps in fertility investigations. Hysterosalpingography (HSG) is the most common first-line diagnostic test used for this purpose (Crosignani and Rubin, 2000 ; National Collaborating Centre for Women's and Children 's Health, 2004; Lanzani et al., 2009) . In addition to assessing tubal patency, HSG also provides an image of the outline of the uterine cavity. It has also been suggested that HSG has a therapeutic role in enhancing subfertility (Mackey et al., 1971 ; DeCherney et al., 1980; Schwabe et al., 1983; Rasmussen et al., 1987; Yaegashi et al., 1987) . As a relatively inexpensive outpatient procedure, HSG fulfils many attributes of a first-line test for tubal patency (Siegler, 1983; Nielsen et al., 1987 ; National Collaborating Centre for Women's and Children 's Health, 2004) . Nevertheless HSG has certain limitations, which have prompted us to query its present role when newer modalities, such as the Chlamydia antibody titre (CAT) test and hysterosalpingo contrast sonography (HyCoSy), are readily available.
Diagnostic accuracy
Laparoscopy is commonly viewed as the gold standard in diagnosing tubal patency. It also provides an opportunity to diagnose and treat endometriosis and peritubal adhesions. However, it is an invasive and expensive procedure requiring general anaesthesia with a 0.13% risk of surgical complications (Chapron et al., 1998) . Furthermore, facilities for surgery may not be readily available in every clinic. Hence, laparoscopy is unsuitable for routine use in subfertile women on a large-scale. Obtaining a reliable estimate of the risk of tubal pathology by another method, prior to proceeding with laparoscopy, would allow only high-risk patients to be selected for this procedure. Hence, HSG and CAT have been suggested for the initial investigation.
HSG has been reported to have a sensitivity and specificity of 53 and 87%, respectively, for any tubal pathology and 46 and 95%, respectively, for bilateral tubal pathology when compared with laparoscopy (Broeze et al., 2010) . The discriminatory capacity of CAT is comparable with that of HSG in the diagnosis of tubal occlusion (Mol et al., 1997) , while HyCoSy is as accurate as HSG in terms of establishing tubal patency (Campbell et al., 1994; Heikkinen et al., 1995) (Table I ) when compared with laparoscopy. HyCoSy has the additional advantage of allowing an ultrasound assessment of the pelvis at the same time and is superior in detection of intrauterine abnormalities (Alatas et al., 1997) , such as endometrial polyps, submucosal fibroids, synechiae as well as hydrosalpinges and abnormal ovaries (Steinkeler et al., 2009) .
Hence, laparoscopy remains the gold standard for those who wish to have a definitive diagnosis. However, all three (CAT, HSG and HyCoSy) tests are proved to have similar accuracy in terms of identifying women who should have laparoscopy.
Radiation exposure
Women undergoing HSG are exposed to pelvic radiation. The mean dose-area product (DAP) for a complete HSG examination is 2.05 Gy cm 2 . In comparison, the mean DAP for a single posterioranterior chest X-ray examination is 0.09 Gy cm 2 (Hart et al., 2009 ).
In contrast, there is no exposure to radiation associated with HyCoSy and CAT.
Use of contrast media
HSG is performed by the passage of a radio-opaque dye from the cervical canal into the uterine cavity under fluoroscopic guidance (Bendick, 1947) . HSG can be performed using water or oil-soluble contrast medium (OSCM). Although there are reports that the use of OSCM in HSG increases the chance of spontaneous pregnancy (Luttjeboer et al., 2007) , they are associated, rarely, with oil embolism and granulomatous inflammation in the presence of obstructed or inflamed Fallopian tubes. Water-soluble contrast medium, which produces superior radiographic images, is currently seen as the preferred medium (Mackey et al., 1971; Soules and Spadoni, 1982; Schwabe et al., 1983) . However, water-soluble contrast materials have been linked with an increased frequency and duration of bleeding after HSG and higher post-HSG miscarriage rates Spring et al., 2000) . It has been suggested that we should use water-soluble contrast media to demonstrate tubal patency followed by OSCM for its therapeutic advantage; however, this will increase the cost, time and discomfort associated with the procedure (DeCherney et al., 1980) . Nevertheless, all types of media contain iodine, and hence are not suitable for use in women who are sensitive to iodine. HyCoSy does not require the use of iodine or involve exposure to radiation. HyCoSy has traditionally been performed using ultrasound contrast media; however, saline and air have been suggested as alternatives (Spalding et al., 1997; Boudghene et al., 2001 ).
Organization of procedures
HyCoSy can be carried out as an office procedure by specialists in reproductive medicine without the input from radiology services (as for HSG) (Schlief and Deichert., 1991; Deichert et al., 1992; Campbell et al., 1994) , while CAT is a blood test that can be arranged from primary care. Both HyCoSy and HSG can only be performed at a certain time in the menstrual cycle. Alternatively, patients are advised to use contraception, which means that they loose at least 1 month in terms of trying for pregnancy. However, CAT determination from a blood test can be performed at any time during the cycle, without the need to avoid pregnancy.
Cost
CAT, being a blood test, is much less expensive than HyCoSy or HSG (Table I ). The costs of HSG and HyCoSy are similar. The cost of HyCoSy can be further reduced by using air/saline as a medium rather than sonographic contrast media (Spalding et al., 1997) , although some authors believe that the physician learning curve for air/saline is longer when compared with the ultrasound contrast.
There are no studies in the literature to determine whether initial investigation with CAT followed by further investigations is a costeffective approach when compared with using HSG or HyCoSy in all women followed by laparoscopy.
Patient comfort
Although there are no differences in patient preference for both the procedures, HyCoSy is associated with less pain (Skinner et al., 2000; Ahinko-Hakamaa et al., 2007) and is better tolerated when compared with HSG (Ayida et al., 1996) .
Discussion
Tubal damage can have various causes, including pelvic infection (most commonly Chlamydia trachomatis), endometriosis and fibroids. A detailed history, examination and pelvic ultrasound should raise suspicion of the presence of fibroids and or significant endometriosis. Further pelvic evaluation in these cases is needed by laparoscopy +/2 hysteroscopy. Most asymptomatic tubal pathology is mainly attributed to the history of pelvic inflammatory disease (PID), (Trimbos-Kemper et al., 1982) , the main agent being C. trachomatis (Anonymous, 1979 (Anonymous, , 1982 . There is a strong association between CATs and tubal subfertility (Punnonen et al., 1979; Simmons et al., 1979; Treharne et al., 1979; Malik et al., 2009 ). As significant cross reactivity with Chlamydia pneumoniae is encountered, CAT does not provide 100% sensitivity and specificity (Land et al., 2003) . However, evidence of past Chlamydia infection using serology is readily available and the test is simple and quick to perform. Microimmunofluorescence (MIF) is widely used for CAT testing and recently a species-specific MIF and ELISA test have been introduced.
While CAT does not provide any detail on the anatomy of the uterus and tubes, it should be able to identify women who need further tubal or pelvic evaluation. So while a negative CAT can be reassuring, a positive test would warrant more invasive diagnostic procedures, such as laparoscopy, to assess the severity of the disease even if there is no history of chlamydial PID. CAT testing adds valuable information to a woman's risk profile based on her medical history. The combination of medical history and CAT testing has a better yield for diagnosing tubal disease than either of these alone (Coppus et al., 2007) . The decision for laparoscopy should take the woman's age and duration of subfertility into consideration. Above a certain age, laparoscopy would be neither meaningful to the patient nor costeffective as her naturally reduced fertility means she would not have the time to await spontaneous conception. In those circumstances, it might be preferable to proceed to IVF directly.
The Dutch Society for Obstetrics and Gynaecology (NVOG) recommends the use of CAT as a first-line test in the basic work-up of subfertile couples, with a fixed cut-off level (immunoglobulin G MIF 1:32 or ELISA 1.1) above which post-infectious pelvic disease should be ruled out with laparoscopy and chromotubation (Swart et al., 1995; Coppus et al., 2007) .
In CAT-positive patients, HSG should be omitted to avoid the 10% risk of post-HSG complications (den Hartog et al., 2008) . Although Hysterosalpingogram as first-line investigation there are no data in the literature to suggest that there are complications following HyCoSy in CAT-positive women, one would assume that the same principles, as for HSG, should apply. Of the 669 subfertile women undergoing HyCoSy, 2.0% required postprocedural drug treatment for pain relief, mild vasovagal reactions were experienced in 4.1%, 0.8% had a severe vasovagal reaction but no late complications were reported (Savelli et al., 2009) . Dessole et al. (2003) have described a series of HyCoSy in, among others, subfertile women: of the 313 subfertile women undergoing HyCoSy, the risk of complications was 4% (fever, PID); two women even required surgery for infectious complications. Although the Chlamydia antibody status was not mentioned, it is plausible that the women harboured Chlamydia and had a (relative) contra-indication for HyCoSy.
In CAT-negative patients, HyCoSy should be recommended. Proponents of HSG would argue that HSG can be performed in a lowresource setting and does not need the availability of ultrasound. However, one still needs X-ray and fluoroscopic equipment as a minimum. Moreover, most subfertility clinics in the developed world have access to ultrasound as part of the basic workup. The need for liaison with another department and exposure to pelvic radiation can be avoided if HyCoSy is advocated instead of HSG.
Conclusion
CAT is comparatively inexpensive, less invasive and can be performed at any time during the menstrual cycle and can identify patients who need further evaluation. Laparoscopy remains the gold standard in diagnosing tubal pathology. We question whether HSG should still be performed as part of modern fertility investigations.
We also suggest a flow chart of investigations for determining tubal pathology in women with subfertility as a compromise between invasiveness and diagnostic accuracy (Fig. 1) , rather than a blanket policy of using HSG. For CAT-positive patients, laparoscopy may be warranted, whereas CAT-negative patients should have a HyCoSy that carries a similar cost and has at least the same accuracy as HSG while avoiding radiation. We feel that HSG is out of date and has no place in modern evidence-based fertility investigations.
